Cargando…

Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities

BACKGROUND: We aimed to evaluate whether the severity of obstructive sleep apnea syndrome (OSAS) per se affects the prevalence of left ventricular (LV) diastolic dysfunction in patients without comorbidities. METHODS: A total of 42 patients with first-diagnosed severe OSAS [apnea–hypopnea index (AHI...

Descripción completa

Detalles Bibliográficos
Autores principales: Papanikolaou, John, Ntalapascha, Melpomeni, Makris, Demosthenes, Koukoubani, Triantafyllia, Tsolaki, Vasiliki, Zakynthinos, George, Gourgoulianis, Konstantinos, Zakynthinos, Epaminondas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769220/
https://www.ncbi.nlm.nih.gov/pubmed/31566076
http://dx.doi.org/10.1177/1753466619880076
_version_ 1783455201971142656
author Papanikolaou, John
Ntalapascha, Melpomeni
Makris, Demosthenes
Koukoubani, Triantafyllia
Tsolaki, Vasiliki
Zakynthinos, George
Gourgoulianis, Konstantinos
Zakynthinos, Epaminondas
author_facet Papanikolaou, John
Ntalapascha, Melpomeni
Makris, Demosthenes
Koukoubani, Triantafyllia
Tsolaki, Vasiliki
Zakynthinos, George
Gourgoulianis, Konstantinos
Zakynthinos, Epaminondas
author_sort Papanikolaou, John
collection PubMed
description BACKGROUND: We aimed to evaluate whether the severity of obstructive sleep apnea syndrome (OSAS) per se affects the prevalence of left ventricular (LV) diastolic dysfunction in patients without comorbidities. METHODS: A total of 42 patients with first-diagnosed severe OSAS [apnea–hypopnea index (AHI) > 30] and 25 controls (AHI < 5), having been referred for snoring to the Sleep Laboratory Department of our tertiary Hospital, were enrolled in the study. Inclusion criteria were absence of any cardiovascular or oxidative stress-related comorbidities, and age between 20 and 70 years. Clinical, laboratory, echocardiographic, and polysomnographic data were recorded prospectively. Diastolic dysfunction diagnosis and grading was based on 2016 ASE/EACVI recommendations. RESULTS: Severe OSAS was associated with significantly increased prevalence and degree of diastolic dysfunction (26/42; 61.9%) compared with controls (7/25; 28%) (p = 0.007). AHI ⩾ 55 (dichotomous value of severe OSAS subset) was also characterized by greater prevalence and degree of diastolic dysfunction compared with 30 < AHI < 55 patients (p = 0.015). In the severe OSAS subset, age >45 years-old, height <1.745 m, body-mass index (BMI) >27.76 kg m(−2), OSAS severity (AHI > 57.35), oxidative stress (overnight reduction of reduced to oxidized glutathione ratio < 18.44%), and BMI/height ratio > 16.155 kg m(−3) (an index describing ‘dense’, short-heavy patients) presented significant diagnostic utility in identifying diastolic dysfunction in ROC-curve analysis (0.697 ⩾ AUC ⩾ 0.855, 0.001 ⩽ p ⩽ 0.018). In binary logistic regression model, advanced age (OR 1.23, 95% CI 1.025–1.477; p = 0.026) and AHI (OR 1.123, 95% CI 1.007–1.253; p = 0.036) showed independent association with diastolic dysfunction in severe OSAS. CONCLUSIONS: The present prospective study may suggest that severe OSAS is significantly associated with LV diastolic dysfunction; OSAS clinical severity exerts a positive influence on (and possibly constitutes an independent risk factor of) LV diastolic dysfunction. The reviews of this paper are available via the supplementary material section.
format Online
Article
Text
id pubmed-6769220
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-67692202019-10-18 Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities Papanikolaou, John Ntalapascha, Melpomeni Makris, Demosthenes Koukoubani, Triantafyllia Tsolaki, Vasiliki Zakynthinos, George Gourgoulianis, Konstantinos Zakynthinos, Epaminondas Ther Adv Respir Dis Original Research BACKGROUND: We aimed to evaluate whether the severity of obstructive sleep apnea syndrome (OSAS) per se affects the prevalence of left ventricular (LV) diastolic dysfunction in patients without comorbidities. METHODS: A total of 42 patients with first-diagnosed severe OSAS [apnea–hypopnea index (AHI) > 30] and 25 controls (AHI < 5), having been referred for snoring to the Sleep Laboratory Department of our tertiary Hospital, were enrolled in the study. Inclusion criteria were absence of any cardiovascular or oxidative stress-related comorbidities, and age between 20 and 70 years. Clinical, laboratory, echocardiographic, and polysomnographic data were recorded prospectively. Diastolic dysfunction diagnosis and grading was based on 2016 ASE/EACVI recommendations. RESULTS: Severe OSAS was associated with significantly increased prevalence and degree of diastolic dysfunction (26/42; 61.9%) compared with controls (7/25; 28%) (p = 0.007). AHI ⩾ 55 (dichotomous value of severe OSAS subset) was also characterized by greater prevalence and degree of diastolic dysfunction compared with 30 < AHI < 55 patients (p = 0.015). In the severe OSAS subset, age >45 years-old, height <1.745 m, body-mass index (BMI) >27.76 kg m(−2), OSAS severity (AHI > 57.35), oxidative stress (overnight reduction of reduced to oxidized glutathione ratio < 18.44%), and BMI/height ratio > 16.155 kg m(−3) (an index describing ‘dense’, short-heavy patients) presented significant diagnostic utility in identifying diastolic dysfunction in ROC-curve analysis (0.697 ⩾ AUC ⩾ 0.855, 0.001 ⩽ p ⩽ 0.018). In binary logistic regression model, advanced age (OR 1.23, 95% CI 1.025–1.477; p = 0.026) and AHI (OR 1.123, 95% CI 1.007–1.253; p = 0.036) showed independent association with diastolic dysfunction in severe OSAS. CONCLUSIONS: The present prospective study may suggest that severe OSAS is significantly associated with LV diastolic dysfunction; OSAS clinical severity exerts a positive influence on (and possibly constitutes an independent risk factor of) LV diastolic dysfunction. The reviews of this paper are available via the supplementary material section. SAGE Publications 2019-09-30 /pmc/articles/PMC6769220/ /pubmed/31566076 http://dx.doi.org/10.1177/1753466619880076 Text en © The Author(s), 2019 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Papanikolaou, John
Ntalapascha, Melpomeni
Makris, Demosthenes
Koukoubani, Triantafyllia
Tsolaki, Vasiliki
Zakynthinos, George
Gourgoulianis, Konstantinos
Zakynthinos, Epaminondas
Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities
title Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities
title_full Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities
title_fullStr Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities
title_full_unstemmed Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities
title_short Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities
title_sort diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769220/
https://www.ncbi.nlm.nih.gov/pubmed/31566076
http://dx.doi.org/10.1177/1753466619880076
work_keys_str_mv AT papanikolaoujohn diastolicdysfunctioninmenwithsevereobstructivesleepapneasyndromebutwithoutcardiovascularoroxidativestressrelatedcomorbidities
AT ntalapaschamelpomeni diastolicdysfunctioninmenwithsevereobstructivesleepapneasyndromebutwithoutcardiovascularoroxidativestressrelatedcomorbidities
AT makrisdemosthenes diastolicdysfunctioninmenwithsevereobstructivesleepapneasyndromebutwithoutcardiovascularoroxidativestressrelatedcomorbidities
AT koukoubanitriantafyllia diastolicdysfunctioninmenwithsevereobstructivesleepapneasyndromebutwithoutcardiovascularoroxidativestressrelatedcomorbidities
AT tsolakivasiliki diastolicdysfunctioninmenwithsevereobstructivesleepapneasyndromebutwithoutcardiovascularoroxidativestressrelatedcomorbidities
AT zakynthinosgeorge diastolicdysfunctioninmenwithsevereobstructivesleepapneasyndromebutwithoutcardiovascularoroxidativestressrelatedcomorbidities
AT gourgoulianiskonstantinos diastolicdysfunctioninmenwithsevereobstructivesleepapneasyndromebutwithoutcardiovascularoroxidativestressrelatedcomorbidities
AT zakynthinosepaminondas diastolicdysfunctioninmenwithsevereobstructivesleepapneasyndromebutwithoutcardiovascularoroxidativestressrelatedcomorbidities